InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Coleman Mark, Director. Insider active across 1 companies, notably Axsome Therapeutics, Inc.. Aggregated, 5 reports have been logged. Total volume traded: €73k. The latest transaction was filed on 15 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations5 total
€4,1533,496 shares@ €1.1880.0000% mcap5.3% of flow
Common Stock
SEC:0001209191-22-019403:0·
€12,670409 shares@ €30.977334.5% of flow
Common Stock
SEC:0001209191-21-066004·
Ideal exit: 15 Aug 2022 (T+270)
€12,670409 shares@ €30.97730.0001% mcap16.3% of flow
Common Stock
SEC:0001209191-21-066004:0·
Ideal exit: 15 Aug 2022 (T+270)
€24,072500 shares@ €48.143465.5% of flow
Common Stock
SEC:0001209191-21-032250·
Ideal exit: 6 Feb 2022 (T+270)
€24,072500 shares@ €48.14340.0003% mcap31.0% of flow
Common Stock
SEC:0001209191-21-032250:0·
Ideal exit: 6 Feb 2022 (T+270)
5 of 5 declarations
About Coleman Mark
Mark Coleman is a Board Member at Axsome Therapeutics, Inc., a biopharmaceutical company. As a board member, he participates in the strategy and management of the company. His expertise in the pharmaceutical sector is an asset for Axsome.
